Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matrix Corporate Capital was a London-based investment banking and stockbroking firm that provided corporate finance, research, and institutional sales and trading services. As a subsidiary of Matrix Group Limited, the firm specialized in the UK small and mid-cap markets, maintaining a significant focus on the healthcare and life sciences sectors. In July 2012, the corporate finance and stockbroking business of Matrix Corporate Capital was acquired by Panmure Gordon & Co, a move that consolidated Panmure's market position and expanded its sector coverage. Consequently, Matrix Corporate Capital ceased to operate as an independent entity, and its specialized life sciences research and advisory teams were integrated into the acquiring firm.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Matrix Corporate Capital.